EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject_exact:"Pharmaceutical industry"
Narrow search

Narrow search

Year of publication
Subject
All
Pharmaceutical industry 7,815 Pharmaindustrie 7,571 Arzneimittel 2,921 Pharmaceuticals 2,895 Arzneimittelmarkt 1,346 Pharmaceutical market 1,272 Innovation 979 USA 910 United States 873 India 759 Pharmakologie 746 Pharmacology 741 Indien 739 Pharmazeutische Industrie 733 Welt 658 World 658 Deutschland 625 Patent 616 Germany 585 Theorie 565 Theory 565 Industrieforschung 510 Industrial research 502 Innovationsmanagement 414 Innovation management 395 pharmaceutical industry 373 Gesundheitswesen 369 Biotechnology industry 360 Biotechnologie-Industrie 356 Generic drugs 352 Generika 347 Health care system 345 Regulierung 339 Multinationales Unternehmen 337 Regulation 336 Patentrecht 332 Intellectual property rights 331 Patent law 330 Immaterialgüterrechte 328 Lieferkette 326
more ... less ...
Online availability
All
Free 2,432 Undetermined 1,789 CC license 125
Type of publication
All
Article 4,294 Book / Working Paper 4,141 Journal 79 Other 6
Type of publication (narrower categories)
All
Article in journal 2,998 Aufsatz in Zeitschrift 2,998 Graue Literatur 1,019 Non-commercial literature 1,019 Aufsatz im Buch 763 Book section 763 Working Paper 698 Arbeitspapier 684 Hochschulschrift 353 Thesis 278 Case study 212 Fallstudie 212 Collection of articles of several authors 163 Sammelwerk 163 Aufsatzsammlung 92 Bibliografie enthalten 64 Bibliography included 64 Konferenzschrift 57 Dissertation u.a. Prüfungsschriften 56 research-article 52 Amtsdruckschrift 51 Government document 51 Conference proceedings 34 Business report 31 Geschäftsbericht 31 Article 29 No longer published / No longer aquired 28 Market information 25 Marktinformation 25 Conference paper 21 Konferenzbeitrag 21 case-report 20 Collection of articles written by one author 19 Sammlung 19 Statistik 16 Festschrift 15 Lehrbuch 15 Statistics 13 review-article 13 Bibliografie 12
more ... less ...
Language
All
English 6,963 German 950 Undetermined 367 French 102 Spanish 49 Italian 39 Russian 20 Portuguese 13 Hungarian 6 Polish 5 Swedish 5 Dutch 4 Croatian 3 Arabic 1 Danish 1 Finnish 1 Japanese 1 Kazakh 1 Norwegian 1 Romanian 1 Slovenian 1 Turkish 1 Ukrainian 1
more ... less ...
Author
All
Berndt, Ernst R. 45 Lichtenberg, Frank R. 44 Higgins, Matthew J. 36 Riccaboni, Massimo 35 Pammolli, Fabio 34 Danzon, Patricia Munch 29 Grabowski, Henry G. 27 Rudholm, Niklas 27 Cockburn, Iain 26 Orsenigo, Luigi 25 Vernon, John A. 24 Henderson, Rebecca 22 Scherer, Frederic M. 22 Granlund, David 21 Chatterjee, Chirantan 20 Lakdawalla, Darius 20 Sampat, Bhaven N. 20 Azoulay, Pierre 19 Seldeslachts, Jo 19 Mehralian, Gholamhossein 18 Scott Morton, Fiona 18 Ceccagnoli, Marco 17 Dubois, Pierre 17 Golec, Joseph 17 Nicholson, Sean 17 Philipson, Tomas J. 17 Phlippen, Sandra 17 Brekke, Kurt R. 16 Harms, Fred 16 Kyle, Margaret K. 16 McGuire, Thomas G. 16 Newham, Melissa 16 Comanor, William S. 15 Li, Danielle 15 Siebert, Ralph 15 Chaudhuri, Sudip 14 Kale, Dinar 14 Ornaghi, Carmine 14 Straume, Odd Rune 14 Towse, Adrian 14
more ... less ...
Institution
All
National Bureau of Economic Research 120 OECD 27 eSocialSciences 14 European Commission / Directorate-General for Health and Food Safety 11 Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München 11 United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT) 10 Bundesverband der Pharmazeutischen Industrie 9 Springer Fachmedien Wiesbaden 9 Europäische Kommission 8 Verband Forschender Arzneimittelhersteller 8 Edward Elgar Publishing 7 Interpharma 7 Université Paris-Dauphine (Paris IX) 7 World Bank 7 Department of Economics and Business, Universitat Pompeu Fabra 6 United Nations University, Maastricht Economic and social Research and training centre on Innovation and Technology 6 World Trade Organization 6 Großbritannien / Office of Health Economics 5 UNCTAD / Secretariat 5 UNIDO 5 American Enterprise Institute for Public Policy Research 4 Economists Advisory Group 4 European Commission / Directorate-General for Migration and Home Affairs 4 European Monitoring Centre for Drugs and Drug Addiction 4 European Parliament / Directorate-General for Internal Policies of the Union 4 F. Hoffmann-La Roche AG 4 Fraunhofer-Institut für Systemtechnik und Innovationsforschung 4 Institutionen för Nationalekonomi, Umeå Universitet 4 Medizinisch-Pharmazeutische Studiengesellschaft 4 Novartis AG 4 Organisation for Economic Co-operation and Development 4 UNCTAD 4 United Nations Conference on Trade and Development 4 Association of the British Pharmaceutical Industry 3 Centre for Health Economics, Department of Economics and Related Studies 3 Centre for Innovation, Research and Competence in the Learning Economy (CIRCLE), Lunds Universitet 3 Department of Economics and Finance, College of Business and Economics 3 Economics Group, Business School 3 Economics, Markets, Institutions, IMT Lucca Institute for Advanced Studies 3 Esomar 3
more ... less ...
Published in...
All
NBER working paper series 120 NBER Working Paper 89 Working paper / National Bureau of Economic Research, Inc. 77 International journal of pharmaceutical and healthcare marketing : IJPHM 70 Journal of medical marketing : device, diagnostic and pharmaceutical marketing 67 Research policy : policy, management and economic studies of science, technology and innovation 57 Journal of health economics 55 SpringerLink / Bücher 52 The European journal of health economics : HEPAC ; health economics in prevention and care 46 Technology analysis & strategic management 38 International journal of the economics of business 35 Health economics 34 International journal of technology management : IJTM 32 Management science : journal of the Institute for Operations Research and the Management Sciences 30 Industrial and corporate change 28 Research paper 28 Europäische Hochschulschriften / 5 27 PharmacoEconomics 27 Health marketing quarterly 26 International journal of pharmaceutical and healthcare marketing 26 Strategic management journal 25 Technological forecasting & social change : an international journal 25 Managerial and decision economics : MDE ; the international journal of research and progress in management economics 24 Pharmaceutical markets and insurance worldwide 23 Journal of business ethics : JOBE 22 Pharmamarketing : gesundheitsökonomische Aspekte einer innovativen Industrie am Beispiel von Deutschland, Österreich und der Schweiz 21 R & D management 19 International journal of industrial organization 18 International journal of production economics 18 Journal of business research : JBR 18 Working paper 18 Applied economics 17 European journal of operational research : EJOR 17 International journal of production research 17 Gabler Edition Wissenschaft 16 Technovation : the international journal of technological innovation, entrepreneurship and technology management 15 Discussion papers / CEPR 14 Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies 14 Organization science : a journal of the Institute for Operations Research and the Management Sciences ; bridging disciplines to advance knowledge of organizations 14 Working Papers / eSocialSciences 14
more ... less ...
Source
All
ECONIS (ZBW) 7,758 RePEc 354 USB Cologne (EcoSocSci) 219 Other ZBW resources 108 EconStor 51 BASE 25 ArchiDok 5
more ... less ...
Showing 1 - 50 of 8,520
Cover Image
Operations management in the pharmaceutical industry
Anand, Gopesh; Ball, George P.; Gray, John V.; … - In: Journal of operations management 71 (2025) 3, pp. 302-313
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376789
Saved in:
Cover Image
Supply base attributes and diversion risk in a supply chain for hazardous pharmaceutical products
Skilton, Paul F.; Mackelprang, Alan; Sepehrirad, Ramin; … - In: Journal of operations management 71 (2025) 3, pp. 373-392
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376815
Saved in:
Cover Image
Efficiency and super-efficiency in the CRO industry, 2012-2021 : a two-stage exploration
Díaz, Ricardo F.; Sánchez-Robles Rute, Blanca - In: Managerial and decision economics : MDE ; the … 46 (2025) 2, pp. 810-831
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376857
Saved in:
Cover Image
Competition and pharmaceutical innovation : the moderating role of size and age of leading companies in the market
Jung, Ye Lim; Yoo, Hyoung Sun - In: IEEE transactions on engineering management : EM ; a … 71 (2024), pp. 3088-3097
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405937
Saved in:
Cover Image
Supply chain disruptions during COVID-19 pandemic : key lessons from the pharmaceutical industry
Takawira, Blessing; Pooe, Raborale I. D. - In: South African journal of business management 55 (2024) 1, pp. 1-10
Purpose: This study extends previous research by exploring the key lessons learned by the pharmaceutical industry in South Africa from the COVID-19 pandemic supply chain disruptions. Design/methodology/approach: Having embraced the interpretivist paradigm, 25 supply chain professionals were...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015196528
Saved in:
Cover Image
Strategic imperatives for digitisation of the Ukrainian pharmaceutical industry
Safonov, Yuriy; Korotun, Olha; Khmurova, Viktoriia - In: Baltic Journal of Economic Studies 10 (2024) 2, pp. 238-251
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015152961
Saved in:
Cover Image
The role of Information Technology and employee engagement in enhancing Knowledge Management in the pharmaceutical Research and Development process : insights from dynamic capabilities theory
Chatzifoti, Natalia; Didaskalou, Eleni A.; Chountalas, … - In: Businesses 4 (2024) 3, pp. 315-330
This study investigates the impact of Information Technology and employee engagement on the implementation of Knowledge Management within the Research and Development processes of pharmaceutical companies. Based on Dynamic Capabilities Theory, this research examines the interaction between these...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015098513
Saved in:
Cover Image
Dusting off the old ones : drug licensing to startups, innovation success and efficiency
Hammoudeh, Mosab; Krieger, Joshua L.; Xu, Jiajie - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014529873
Saved in:
Cover Image
Sustaining the integration of social objectives over time : a case-based analysis of access to medicine in the pharmaceutical industry
Bünder, Tobias; Rathert, Nikolas; Mair, Johanna - In: Business & society 63 (2024) 5, pp. 1110-1148
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014577841
Saved in:
Cover Image
MSD : continuous pharmaceutical manufacturing data for the 2024 MSOM Data-Driven Research Challenge
Martagan, Tugce; Baaijens, Marc; Dirckx, Coen; Holman, James - In: Manufacturing & service operations management : M & SOM 26 (2024) 5, pp. 1587-1604
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015130716
Saved in:
Cover Image
Does uncertainty boost exports? : a study on the effect of innovation and marketing capabilities in a small and innovation-intensive sector
Vieira, Jorge; Frade, Rui; Martinho, Filipa; Martinho, … - In: Economies : open access journal 11 (2023) 1, pp. 1-20
The main goal of this research is to study the impact of uncertainty on export performance, from a resource-based perspective. Despite the ample research on how economies behave during periods of high uncertainty, there is still a poor understanding of how this affects smaller sectors,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013500906
Saved in:
Cover Image
Covid-19 and the South African pharmaceutical supply chain : drivers, strategies, and recommendations
Takawira, Blessing; Pooe, David Rabolane Isaac - In: International Journal of Research in Business and … 12 (2023) 8, pp. 12-23
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014452622
Saved in:
Cover Image
A strategic response to COVID-19 induced supply chain disruption in South Africa's pharmaceutical industry
Takawira, Blessing; Mutambara, Emmanuel - In: International Journal of Research in Business and … 12 (2023) 8, pp. 61-73
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014452636
Saved in:
Cover Image
Analysis of trends in the development of the pharmaceutical market of Ukraine in 2007-2021
Mashchenko, Olga; Serhieieva, Lyudmila; Shyshka, Іhor - In: Baltic Journal of Economic Studies 9 (2023) 3, pp. 145-150
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015141689
Saved in:
Cover Image
The impact of firm-based organizational citizenship behavior on continuance and normative commitment among pharmaceutical executives : an SEM approach
Oamen, Theophilus Ehidiamen - In: Journal of economics & management 45 (2023) 1, pp. 47-67
Aim/purpose - The study was based on social exchange theory and addressed the effects of firm-based organizational citizenship behavior (OCB) on normative and continuance organizational commitment (OC). Multigroup behavioral differences among pharmaceutical executives were also evaluated....
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014325196
Saved in:
Cover Image
Application de l'exception Bolar: Différentes approches dans le droit de l'UE
Doubinsky, Dmytro - 2025
This Research Paper addresses the growing problem of access to essential medicines, focusing on the role of intellectual property rights, particularly patent rights, in restricting access by enabling pharmaceutical market monopolies that keep drug prices high. The paper explores the Bolar...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015407554
Saved in:
Cover Image
Women Leaders in the Strategic Positions of Pharmaceutical Companies: Overcoming Barriers and Systemic Biases
Nyeleti Mayimele, Nsovo - In: Business Ethics and Leadership 9 (2025) 1, pp. 65-78
The United Nations Sustainable Development Goal (SDG) 5 aims to achieve gender equality and empower all women and girls, emphasising the importance of ensuring full and effective participation and equal opportunities for leadership at all levels of decision-making in political, economic and...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015420576
Saved in:
Cover Image
Greening the pharmaceutical supply chain
Belal, Md Mostain; Shukla, Vinaya; Sreejith Balasubramanian - In: Business strategy and the environment 34 (2025) 2, pp. 1917-1948
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015357789
Saved in:
Cover Image
Application de l'exception Bolar : différentes approches dans le droit de l'UE
Doubinsky, Dmytro - 2025
This Research Paper addresses the growing problem of access to essential medicines, focusing on the role of intellectual property rights, particularly patent rights, in restricting access by enabling pharmaceutical market monopolies that keep drug prices high. The paper explores the Bolar...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015358929
Saved in:
Cover Image
Evaluating quality reward and other interventions to mitigate US drug shortages
Naumov, Sergey; Noh, In Joon; Zhao, Hui - In: Journal of operations management 71 (2025) 3, pp. 335-372
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376804
Saved in:
Cover Image
Home remedies : flexibilities to onshore pharmaceutical manufacturing under WTO rules
Mitchell, Andrew D. - In: Journal of international economic law 28 (2025) 1, pp. 23-42
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015425609
Saved in:
Cover Image
Going through the roof : on prices for drugs sold through insurance
Kamphorst, Jurjen; Karamychev, Vladimir A. - In: Games and economic behavior 151 (2025), pp. 218-242
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015426723
Saved in:
Cover Image
Orphan medicines in the EU
European Medicines Agency - 2025
Finding effective treatment for patients with rare diseases can be very difficult. Since the EU orphan regulations entered into force in 2000, it has played a central role in facilitating the development and authorisation of medicines for rare diseases.
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015428269
Saved in:
Cover Image
Firm-level innovation and the role of political capabilities : evidence for the pharmaceuticals industry
Saha, Amrita; Pozo Segura, Juan Manuel del; Palazzo, Gabriel - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405762
Saved in:
Cover Image
Deciphering the risk-return dynamics of pharmaceutical companies using the GARCH-M model
Kaur, Arvinder; Chavali, Kavita - In: Risks : open access journal 13 (2025) 5, pp. 1-24
This study focuses on the precise forecasting of stock price movement to determine returns, diversify risk, and demystify existing opportunities. It also aims to gauge the difference in terms of the stock volatility of various pharma companies before and during the pandemic era. The prediction...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015409027
Saved in:
Cover Image
Evaluation of operational efficiency in China's pharmaceutical industry and analysis of environmental impacts
Sun, Jiaqiang; Rosli, Anita Binti; Daud, Adrian; Yan, Xia - In: Economies : open access journal 13 (2025) 4, pp. 1-35
The pharmaceutical industry is a cornerstone of national economies and plays a critical role in public health. However, China's pharmaceutical industry faces significant challenges, including regional disparities in development. The existing research on operational efficiency evaluation...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015410063
Saved in:
Cover Image
The International Finance Corporation's Investments in the Pharmaceutical and Life Sciences Sector
World Bank - 2025
This clustered Project Performance Assessment Report (PPAR) chapeau report synthesizes evaluation findings from six International Finance Corporation (IFC) investment projects in the pharmaceutical and life sciences sector, specifically targeting generic prescription drugs and consumer health...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015454303
Saved in:
Cover Image
Recycling behavior in take-back programs : exploring driving factors and nudge-based interventions for end-user engagement : evidence From Novo Nordisk's take-back program Returpen™
Harden, Cecilie Wagner - 2025 - First edition
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015455331
Saved in:
Cover Image
Can the size and duration of clinical trials in new drug applications predict post-approval safety warnings?
Clark, Jeremy; Menclova, Andrea Kutinova - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015394355
Saved in:
Cover Image
Technological autonomy or global integration : navigating vaccine dependency in LMICs
Marin, Anabel; Morales, Jose - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015394620
Saved in:
Cover Image
An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines : evidence from 35 countries
Leon, Giovanny; Carbonel, Christophe; Rampuria, Aparajit; … - In: The European journal of health economics 26 (2025) 3, pp. 513-536
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015394765
Saved in:
Cover Image
What economists should know about the 340B Drug Discounting Program
Courtemanche, Charles; Garuccio, Joseph - 2025
The 340B Drug Pricing Program was instituted to bolster the health care safety net without relying on taxpayer money. It allows participating health care facilities - most of which are hospitals - to purchase drugs filled at in-house or contracted external pharmacies at discounts from...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015395374
Saved in:
Cover Image
The EU community pharmacy market : the density and its influencing factors
Schwaabe, Selina - 2025
Community pharmacies deliver high-quality health care and are responsible for medication safety. The goal of the government is to ensure nationwide, accessible, and affordable medical health-care services provided by pharmacies. Therefore, the per capita density of community pharmacies matters....
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015211718
Saved in:
Cover Image
Combating vaccine hesitancy : the case of HPV vaccination
Díaz, Lina; Martínez, Déborah; Márquez, Karina; … - 2025
Cervical cancer, primarily caused by persistent Human Papillomavirus (HPV) infection, remains one of the leading causes of cancer-related deaths among women in developing countries. Although HPV vaccines are widely available in these regions, vaccine uptake remains persistently low. To address...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015271625
Saved in:
Cover Image
Privacy regulation and R&D investments : causal evidence from global pharmaceutical and biotechnology firms
Heli, Koski - 2025
This paper examines the effects of data privacy regulation on R&D investment in the pharmaceutical and biotechnology sectors. In these industries, access to personal health data is essential for innovation, particularly in clinical research. Leveraging a firm-level panel of the world's top R&D...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015447150
Saved in:
Cover Image
Drug pricing models, no "one-size-fits-all" approach : a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscape
Manders, Evert A.; Berg, Sibren van den; Visser, Saco J. de - In: The European journal of health economics 26 (2025) 4, pp. 683-696
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015448455
Saved in:
Cover Image
The threat of pharmaceutical crime in the EU and beyond
European Union Agency for Law Enforcement Cooperation - 2025
This report outlines the threat of pharmaceutical crime in the EU and beyond, as assessed by Europol. It aims to raise awareness of the ways criminal networks exploit consumers and industry in generating illegal revenue through producing and selling counterfeit medicines.
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015322789
Saved in:
Cover Image
Optimal co-development contracts for companion diagnostics
Batun, Sakine; Begen, Mehmet A.; Zaric, Gregory S. - In: European journal of operational research : EJOR 323 (2025) 1, pp. 241-252
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015415589
Saved in:
Cover Image
Model evaluation of post-M&A success metrics in the German biopharmaceutical industry
Leschik, Damian - In: Journal of business models : JOBM 13 (2025) 1, pp. 146-167
Purpose: This study evaluates the success metrics of post-merger and acquisition (M&A) activities in the German biopharmaceutical industry, focusing on small- and medium-sized enterprises (SMEs). It examines how metrics such as economies of scale, economies of scope, market share, clinical...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015416050
Saved in:
Cover Image
Long-term performance of technology acquisitions : the role of acquisition program diversity, innovation, and alliance portfolio size : evidence from the pharmaceutical industry
Schweizer, Lars; Wang, Le; Koscher, Eva - In: European management journal 43 (2025) 1, pp. 154-168
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015333120
Saved in:
Cover Image
Exploring corporate capital structure and overleveraging in the pharmaceutical industry
Issa, Samar; Issa, Hussein - In: Risks : open access journal 13 (2025) 2, pp. 1-33
This paper applies an empirical model of corporate capital structure, optimal debt, and overleveraging to estimate overleveraging measured as the difference between actual and optimal debt. Estimated using a sample of the twenty largest pharmaceutical firms, covering the time span from 2000 to...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015333730
Saved in:
Cover Image
A simulation-optimization approach for capacitated lot-sizing in a multi-level pharmaceutical tablets manufacturing process
Simonis, Michael; Nickel, Stefan - In: European journal of operational research : EJOR 324 (2025) 1, pp. 49-61
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015432994
Saved in:
Cover Image
Circular economy application in pharmaceutical supply chains in the UK : a holistic evolutionary game approach
Nami, Nazanin; Pishchulov, Grigory; Frota Neto, Joao … - In: European journal of operational research : EJOR 326 (2025) 3, pp. 451-466
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015433450
Saved in:
Cover Image
Role of pharmacists in generic pharmaceutical adoption
Kakehi, Haruo; Nakajima, Ryo - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015187356
Saved in:
Cover Image
Passthrough of retail price regulation in the market for pharmaceuticals
Jaakko, Markkanen - 2025
I study the passthrough of regulated ad valorem pharmacy markups and reduced Value Added Tax (VAT) rates to pharmaceutical retail prices in Finland. My reduced form evidence shows that pharmaceutical manufacturers respond to a decrease in regulated pharmacy markups by increasing their wholesale...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015173440
Saved in:
Cover Image
Evaluation of a partial ban of Rx-rebates in Germany using difference-in-differences
Gail, Maximilian M.; Goetz, Georg; Herold, Daniel; … - 2025
In December 2020, Germany implemented a policy restricting online pharmacies from offering rebates on prescription drugs to members of the statutory health insurance. This policy change created a natural experiment, allowing us to analyze its impact on the pharmaceutical market using...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015202669
Saved in:
Cover Image
Integrated shelf-life rules for multi-level pharmaceutical tablets manufacturing processes
Simonis, Michael; Nickel, Stefan - In: International journal of production research 63 (2025) 3, pp. 1046-1066
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015198531
Saved in:
Cover Image
Are M&As spurring or stifling innovation? : evidence from antidiabetic drug development
Malek, Jan; Seldeslachts, Jo; Veugelers, Reinhilde - 2025
This paper provides empirical evidence on which M&A deals spur innovation, and which stifle it. To do so, we consider not only the product market position of the acquiring firm, but also the position of both target and acquirer in the technology space. Focusing on the antidiabetic drugs market,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015434666
Saved in:
Cover Image
Are M&As spurring or stifling innovation? : evidence from antidiabetic drug development
Malek, Jan; Seldeslachts, Jo; Veugelers, Reinhilde - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015435938
Saved in:
Cover Image
Effects of debt financing decisions on profitability : a comparison of USA and Europe biopharmaceutical industry
Nkansah, Emmanuel - In: International Journal of Financial Studies : open … 13 (2025) 3, pp. 1-23
Debt financing is important for financing major investments in the biopharmaceutical industry. Debt financing allows companies to raise funds without giving up ownership or control through indenture and covenants of the company. In this study, I analyze the effects of debt financing decisions on...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015457531
Saved in:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...